Order Article Reprints

Gasanov VAo, Kashirskikh DA, Khotina VA, Lee AA, Nikitochkina SY, Kuzmina DM, Mukhina IV, Vorotelyak EA, Vasiliev AV. Genetically Modified Mesenchymal Stromal/Stem Cells as a Delivery Platform for SE-33, a Cathelicidin LL-37 Analogue: Preclinical Pharmacokinetics and Tissue Distribution in C57BL/6 Mice. Antibiotics. 2025; 14(5):429. https://doi.org/10.3390/antibiotics14050429

Gasanov, Vagif Ali oglu, Dmitry Alexandrovich Kashirskikh, Victoria Alexandrovna Khotina, Arthur Anatolievich Lee, Sofya Yurievna Nikitochkina, Daria Mikhailovna Kuzmina, Irina Vasilievna Mukhina, Ekaterina Andreevna Vorotelyak, and Andrey Valentinovich Vasiliev. 2025. "Genetically Modified Mesenchymal Stromal/Stem Cells as a Delivery Platform for SE-33, a Cathelicidin LL-37 Analogue: Preclinical Pharmacokinetics and Tissue Distribution in C57BL/6 Mice" Antibiotics 14, no. 5: 429. https://doi.org/10.3390/antibiotics14050429

Gasanov, V. A. o., Kashirskikh, D. A., Khotina, V. A., Lee, A. A., Nikitochkina, S. Y., Kuzmina, D. M., Mukhina, I. V., Vorotelyak, E. A., & Vasiliev, A. V. (2025). Genetically Modified Mesenchymal Stromal/Stem Cells as a Delivery Platform for SE-33, a Cathelicidin LL-37 Analogue: Preclinical Pharmacokinetics and Tissue Distribution in C57BL/6 Mice. Antibiotics, 14(5), 429. https://doi.org/10.3390/antibiotics14050429